Clinical trials recruiting for Cholangiocarcinoma
32
Recruiting trials
41
US states with sites
15
Countries
12%
Accept healthy volunteers
Phase breakdown
Drugs and treatments being studied
| Intervention | Trials |
|---|---|
| 18F-FDG | 1 |
| CEA CAR-T cells | 1 |
| CEA-targeted CAR-T cells | 1 |
| Cisplatin | 1 |
| Dexamethasone | 1 |
| Durvalumab | 1 |
| Floxuridine | 1 |
| Fludarabine + Cyclophosphamide combination | 1 |
| GV20-0251 | 1 |
| Gemcitabine | 1 |
| LY4337713 | 1 |
| MGC028 | 1 |
Where trials are recruiting (top US states)
| State | Recruiting trials |
|---|---|
| California | 5 |
| Maryland | 5 |
| Missouri | 4 |
| Massachusetts | 3 |
| Michigan | 3 |
| New York | 3 |
| Pennsylvania | 3 |
| Texas | 3 |
| Florida | 2 |
| Minnesota | 2 |
| North Carolina | 2 |
| Ohio | 2 |
Top cities
Bethesda, Maryland 4St Louis, Missouri 4New York, New York 3Philadelphia, Pennsylvania 3Boston, Massachusetts 2Columbus, Ohio 2Dallas, Texas 2Duarte, California 2Grand Rapids, Michigan 2Houston, Texas 2
Self-screener
Recruiting trials
- 18F-Fibroblast Activation Protein Inhibitor ([18F]FAPI-74) PET Imaging for Cancer Detection
- 18F-T2 PET/CT Imaging for CAIX Positive Solid Tumors
- A Noninvasive and Screening miRNA Signature for Gastrointestinal Cancer
- A Study of GV20-0251 in Advanced or Refractory Solid Tumors
- A Study of LY4337713 in Participants With FAP-Positive Solid Tumors
- A Study of MGC028 in Participants With Advanced Solid Tumors
- Agnostic Therapy in Rare Solid Tumors
- Bile Omics for Diagnosing Indeterminate Biliary Strictures
- Clinical Efficacy and Safety of Paclitaxel Polymeric Micelles for Injection in the Treatment of Patients With Taxans-resistant Pancreatic Adenocarcinoma, Cholangiocarcinoma, Lung Cancer, Gastric Cancer, Esophageal Carcinoma, or Breast Cancer
- Clinical Study of CEA Targeting Chimeric Antigen Receptor T Lymphocytes（CAR-T） for CEA Positive Advanced Malignant Solid Tumors
- Clinical Study of CEA-targeted CAR-T Therapy for CEA-positive Advanced/Metastatic Malignant Solid Tumors
- Durvalumab and Tremelimumab in Combination With Propranolol and Chemotherapy for Treatment of Advanced Hepatopancreabiliary Tumors (BLOCKED)
- Efficacy of Fistulotomy for Biliary Cannulation
- Evaluation of Skin Tests in Biotherapy Allergies
- FAPI-PET Value for the Initial Screening of Pancreatic and Biliary Cancers
- Frequency and Clinical Phenotype of BAP1 Hereditary Predisposition Syndrome
- Implementing a Randomized Control Trial to Test the Expanded Web-based Decision Aid
- In-Depth Characterisation of Biliary Strictures and Hepato-Pancreato-Biliary Focal Lesions for Development of New Technologies to Tackle Hepato-Pancreato-Biliary Cancers
- Laryngopharyngeal Injury After Endotracheal Intubation Under General Anesthesia
- Liver Embolization Approaches for Tumor Management
- Obtaining Solid Tumor Tissue From People Having Biopsy or Surgery for Certain Types of Cancer
- PDS01ADC in Combination With Hepatic Artery Infusion Pump (HAIP) and Systemic Therapy for Subjects With Metastatic Colorectal Cancer, Intrahepatic Cholangiocarcinoma, or Metastatic Adrenocortical Carcinoma
- Pilot Comparing ctDNA IDV vs. SPV Sample in Pts Undergoing Biopsies for Hepatobiliary and Pancreatic Cancers
- Preoperative Evaluation of Lymph Nodes of Cholangiocarcinoma (POELH-III)
- Registry for Advanced Endoscopy
- SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Streamlining Radioembolization for CCC and Metastatic Liver Cancer
- TCR1188-ABC Cells in KRAS-mutated Cancers
- The Relationship Between Triceps Skinfold and Overall Survival of Pancreas, Bile Duct, Gallbladder Cancer
- Tissue Adhesive Glue Modified Cyanoacrylate (Glubran® 2) in Soft Pancreas
- Trop2-targeted immunoPET Imaging of Solid Tumors
- Washington University Participant Engagement and Cancer Genomic Sequencing Center (WU-PE-CGS)
Related conditions
Trials recruiting for Cholangiocarcinoma often also study these conditions. Each links to its own recruiting-trial list.
Pancreatic cancer 870Colorectal cancer 1359Lung cancer 2180Breast cancer 2239Pancreas Cancer 86Ovarian cancer 118Melanoma 487Hepatocellular carcinoma 51Gastric cancer 91Endometrial cancer 68
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for Cholangiocarcinoma trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.